PLASMA CELL MYELOMA RECURRENT

Clinical trials for PLASMA CELL MYELOMA RECURRENT explained in plain language.

Never miss a new study

Get alerted when new PLASMA CELL MYELOMA RECURRENT trials appear

Sign up with your email to follow new studies for PLASMA CELL MYELOMA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Skin jab vs. IV drip: new hope for easier cancer treatment

Disease control Ongoing

This study is testing if a skin injection works as well as the standard intravenous (IV) drip to deliver a drug for relapsed multiple myeloma. It involves over 500 adults whose cancer has returned after previous treatments. The main goal is to see if the injection method is just …

Matched conditions: PLASMA CELL MYELOMA RECURRENT

Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control

Last updated Apr 02, 2026 03:41 UTC

PLASMA CELL MYELOMA RECURRENT

Get alerted when new PLASMA CELL MYELOMA RECURRENT trials appear

Skin jab vs. IV drip: new hope for easier cancer treatment